The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[[(1R)-1-(carboxymethyl)-2-[4-(3-chloro-5-fluorophenyl)phenyl]ethyl]amino]-4-oxobutanoic acid ID: ALA4459630
PubChem CID: 59607723
Max Phase: Preclinical
Molecular Formula: C20H19ClFNO5
Molecular Weight: 407.83
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCC(=O)N[C@@H](CC(=O)O)Cc1ccc(-c2cc(F)cc(Cl)c2)cc1
Standard InChI: InChI=1S/C20H19ClFNO5/c21-15-8-14(9-16(22)10-15)13-3-1-12(2-4-13)7-17(11-20(27)28)23-18(24)5-6-19(25)26/h1-4,8-10,17H,5-7,11H2,(H,23,24)(H,25,26)(H,27,28)/t17-/m1/s1
Standard InChI Key: SLSSIFQQORPRSK-QGZVFWFLSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
4.7835 -2.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6048 -2.3814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0156 -3.0955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8362 -3.0959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2456 -2.3835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8326 -1.6693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0134 -1.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0632 -2.3834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4762 -3.0963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2968 -3.0956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7053 -2.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2913 -1.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4721 -1.6733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3749 -3.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5535 -3.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7835 -3.8051 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3749 -4.5169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7835 -5.2288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5535 -4.5169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3749 -5.9406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7835 -6.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3749 -7.3601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6048 -6.6524 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1449 -2.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3278 -2.3855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5535 -1.6778 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7069 -3.8024 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.6974 -0.9599 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
5 8 1 0
14 1 1 1
14 15 1 0
14 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
15 24 1 0
24 25 2 0
24 26 1 0
10 27 1 0
12 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.83Molecular Weight (Monoisotopic): 407.0936AlogP: 3.51#Rotatable Bonds: 9Polar Surface Area: 103.70Molecular Species: ACIDHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.84CX Basic pKa: ┄CX LogP: 3.20CX LogD: -2.86Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -0.61
References 1. Kawanami T, Karki RG, Cody E, Liu Q, Liang G, Ksander GM, Rigel DF, Schiering N, Gong Y, Coppola GM, Iwaki Y, Sun R, Neubert A, Fan L, Ingles S, D'Arcy A, Villard F, Ramage P, Jeng AY, Leung-Chu J, Liu J, Beil M, Fu F, Chen W, Cumin F, Wiesmann C, Mogi M.. (2020) Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors., 11 (2): [PMID:32071687 ] [10.1021/acsmedchemlett.9b00578 ]